Loading clinical trials...
Loading clinical trials...
By detecting platelet antibodies of participants and then further to identify their genotype and analyzing laboratory examination, the investigators will obtain positive frequency of HPA antibodies, t...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Guangzhou First People's Hospital
Collaborators
NCT06685757 · Antibody-mediated Rejection
NCT04645199 · Multiple Myeloma, Acute Myeloid Leukemia, and more
NCT05004493 · Antibody-mediated Rejection, NMO Spectrum Disorder, and more
NCT04561986 · Antibody-mediated Rejection
NCT00106015 · Anemia, Blood Disease
Guangzhou First People's Hospital
Guangzhou, Guangdong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions